APPLICATION
NDA022048
TYPE
NDA
ORIGINAL APPROVAL
2007-11-29
LATEST ACTION
2014-06-23
ROUTE
OPHTHALMIC, INTRAVITREAL
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
TRIESENCE · ReferencePrescription
TRIAMCINOLONE ACETONIDE 40MG/ML (40MG/ML) · INJECTABLE · INTRAVITREAL
Approval history
2014-06-23Manufacturing (CMC) · Supplement 3 · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.